Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic

Description

This is prospective observational registry study that will assess 1) if the neurocognitive function app (Brainlab Cognition) can be used in a widespread neuro-oncology clinic setting and 2) if patient reported quality of life parameters can be obtained electronically and integrated into clinic.

Conditions

Neurocognitive Disorders

Study Overview

Study Details

Study overview

This is prospective observational registry study that will assess 1) if the neurocognitive function app (Brainlab Cognition) can be used in a widespread neuro-oncology clinic setting and 2) if patient reported quality of life parameters can be obtained electronically and integrated into clinic.

Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic

Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic

Condition
Neurocognitive Disorders
Intervention / Treatment

-

Contacts and Locations

Miami

Miami Cancer Institute, Miami, Florida, United States, 33176

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. All adult (18+) patients with central nervous system (CNS) tumors, both primary brain malignancies and brain metastases, treated with radiotherapy (partial brain, stereotactic radiosurgery, stereotactic fractionated radiotherapy, or whole-brain radiotherapy), surgery, and/or antineoplastic therapy and followed thereafter at Miami Cancer Institute (MCI)
  • 2. Life expectancy ≥ 6 months
  • 3. Willingness to participate in ongoing registration study
  • 1. Patients receiving radiotherapy to the brain for functional disease (arteriovenous malformations, trigeminal neuralgia, essential tremors, etc.)
  • 2. Pediatric patients (\<18 years old), pregnant women, and prisoners.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Baptist Health South Florida,

Rupesh R Kotecha, MD, PRINCIPAL_INVESTIGATOR, Miami Cancer Institute

Study Record Dates

2027-11